Eric Blackstone resumes & CV records
Resumes
Eric Blackstone
Eric G Blackstone Deceased16422 169Th St SE, Monroe, WA 98272
Eric Blackstone Phones & Addresses
Monroe, WA
4849 Sterling Way, Mukilteo, WA 98275
216 Quarry Stone Way, Manteca, CA 95336
San Bruno, CA
San Joaquin, CA
Chatsworth, CA
Simi Valley, CA
Mentions for Eric G Blackstone
Publications & IP owners
Us Patents
Methods, Compositions And Devices For Inducing Stasis In Cells, Tissues, Organs, And Organisms
US Patent:
2008008, Apr 10, 2008
Filed:
Aug 10, 2007
Appl. No.:
11/837484
Inventors:
Mark Roth - Seattle WA, US
Eric Blackstone - Seattle WA, US
Eric Blackstone - Seattle WA, US
Assignee:
Fred Hutchinson Cancer Research Center, Inc. - Seattle WA
International Classification:
A61K 33/04
A61K 31/095
A61K 31/10
A61P 43/00
A61K 33/00
A61K 31/095
A61K 31/10
A61P 43/00
A61K 33/00
US Classification:
424701000, 424699000, 424708000, 514706000, 514708000
Abstract:
The present invention concerns the use of oxygen antagonists for inducing stasis in cells, tissues, and/or organs in vivo or in an organism overall. It includes methods and apparatuses for achieving stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer is provided.
Methods, Compositions And Devices For Inducing Stasis In Cells, Tissues, Organs, And Organisms
US Patent:
2008017, Jul 17, 2008
Filed:
Aug 12, 2007
Appl. No.:
11/837536
Inventors:
Mark B. Roth - Seattle WA, US
Eric Blackstone - Seattle WA, US
Eric Blackstone - Seattle WA, US
Assignee:
Fred Hutchinson Cancer Research Center, Inc. - Seattle WA
International Classification:
A61K 33/00
US Classification:
424600
Abstract:
The present invention concerns the use of oxygen antagonists for inducing stasis in cells, tissues, and/or organs in vivo or in an organism overall. It includes methods and apparatuses for achieving stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer is provided.
Methods, Compositions And Articles Of Manufacture For Enhancing Survivability Of Cells, Tissues, Organs, And Organisms
US Patent:
2008017, Jul 17, 2008
Filed:
Aug 10, 2007
Appl. No.:
11/837491
Inventors:
Mark B. Roth - Seattle WA, US
Mike Morrison - Seattle WA, US
Eric Blackstone - Seattle WA, US
Dana Miller - Seattle WA, US
Mike Morrison - Seattle WA, US
Eric Blackstone - Seattle WA, US
Dana Miller - Seattle WA, US
International Classification:
A61K 31/66
A61K 31/555
A61K 31/185
A61K 31/165
A61K 31/275
A61K 31/26
A61K 31/095
A61K 31/21
A61K 31/555
A61K 31/185
A61K 31/165
A61K 31/275
A61K 31/26
A61K 31/095
A61K 31/21
US Classification:
514114, 514126, 514184, 514514, 514526, 514553, 514621, 514706
Abstract:
The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.
Methods, Compositions And Articles Of Manufacture For Enhancing Survivability Of Cells, Tissues, Organs, And Organisms
US Patent:
2008017, Jul 17, 2008
Filed:
Aug 12, 2007
Appl. No.:
11/837539
Inventors:
Mark B. Roth - Seattle WA, US
Mike Morrison - Seattle WA, US
Eric Blackstone - Seattle WA, US
Dana Miller - Seattle WA, US
Mike Morrison - Seattle WA, US
Eric Blackstone - Seattle WA, US
Dana Miller - Seattle WA, US
International Classification:
A61K 31/66
A61K 31/555
A61K 31/185
A61K 31/165
A61K 31/275
A61K 31/26
A61K 31/095
A61K 31/21
A61P 43/00
A61K 31/555
A61K 31/185
A61K 31/165
A61K 31/275
A61K 31/26
A61K 31/095
A61K 31/21
A61P 43/00
US Classification:
514144, 514126, 514184, 514514, 514526, 514553, 514621, 514706
Abstract:
The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.
Methods And Compositions For Enhancing Survivability Of Cells, Tissues, Organs And Organisms
US Patent:
2012004, Feb 16, 2012
Filed:
Jul 29, 2011
Appl. No.:
13/194635
Inventors:
Mark B. Roth - Seattle WA, US
Mike Morrison - Seattle WA, US
Eric Blackstone - Seattle WA, US
Dana Miller - Seattle WA, US
Mike Morrison - Seattle WA, US
Eric Blackstone - Seattle WA, US
Dana Miller - Seattle WA, US
International Classification:
A61K 33/04
A61P 7/00
A61P 9/10
A61P 9/00
C12N 5/07
A61P 43/00
A61P 7/00
A61P 9/10
A61P 9/00
C12N 5/07
A61P 43/00
US Classification:
424702, 435375
Abstract:
The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.
Methods, Compositions And Articles Of Manufacture For Enhancing Survivability Of Cells, Tissues, Organs, And Organisms
US Patent:
2007007, Apr 5, 2007
Filed:
Apr 20, 2006
Appl. No.:
11/408734
Inventors:
Mark Roth - Seattle WA, US
Mike Morrison - Seattle WA, US
Eric Blackstone - Seattle WA, US
Dana Miller - Seattle WA, US
Mike Morrison - Seattle WA, US
Eric Blackstone - Seattle WA, US
Dana Miller - Seattle WA, US
International Classification:
A61K 31/66
A61K 31/555
A61K 31/185
A61K 31/165
A61K 31/275
A61K 31/26
A61K 31/095
A61K 31/21
A61K 31/555
A61K 31/185
A61K 31/165
A61K 31/275
A61K 31/26
A61K 31/095
A61K 31/21
US Classification:
514114000, 514184000, 514706000, 514126000, 514553000, 514514000, 514526000, 514621000
Abstract:
The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.
Methods, Compositions And Articles Of Manufacture For Enhancing Survivability Of Cells, Tissues, Organs, And Organisms
US Patent:
2016036, Dec 15, 2016
Filed:
Jan 11, 2016
Appl. No.:
14/992637
Inventors:
- Seattle WA, US
Mike Morrison - Seattle WA, US
Eric Blackstone - Seattle WA, US
Dana Miller - Seattle WA, US
Mike Morrison - Seattle WA, US
Eric Blackstone - Seattle WA, US
Dana Miller - Seattle WA, US
International Classification:
A61K 33/04
Abstract:
The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.